Others titles
- US Vaccines National Drug Codes Unit Of Use
- Vaccines NDC Codes Unit Of Use
Keywords
- US Vaccine
- FDA Vaccine
- Vaccine NDC
Vaccines National Drug Codes Unit Of Use
The Vaccines National Drug Codes Unit Of Use database facilitate the use of NDC to identify vaccines.
The purpose of the NDC unit of use dataset is to show the relationships of vaccine primary packaging NDCs and provide related information for use as reference data for solutions that leverage NDCs.
Get The Data
- ResearchNon-Commercial, Share-Alike, Attribution Free Forever
- CommercialCommercial Use, Remix & Adapt, White Label Log in to download
Description
NDCs are assigned by the Federal Drug Administration (FDA) and serve as universal product identifiers for human drugs. These codes indicate the product (FDA Product Code), the manufacturer or packager (FDA Labeler Code), and the packaging (e.g. 5 dose vial).
The format of these codes varies within each component (4-4-2, 5-3-2, or 5-4-1). The combinations of these components have 10 numbers.
In many uses, these 3 components are normalized to a consistent pattern (5-4-2) with dashes between components. A component is left-padded with zero (0) to adjust the size. These more familiar codes are labeled NDC11 in these pages.
In most cases, there are separate NDCs for the Unit of Use (primary) and Unit of Sale (secondary) packaging of a vaccine. That is, the syringe that contains the vaccine has one NDC and the carton of 10 syringes has a different NDC.
Primary package: The container (i.e. vial or syringe) that holds the vaccine. This is generally referred to as the vaccine’s Unit of Use.
Some vaccines (primary package) contain multiple components (e.g. lyophilized agent and diluent agent). The individual components of a multi-component vaccine are each assigned a unique NDC. The NDCs of the individual components differ from the NDC of the secondary packaging.
Each of these component packages (unit of use) will be linked to the unit of sale package.
About this Dataset
Data Info
Date Created | 2015-06 |
---|---|
Last Modified | 2023-07-27 |
Version | 2023-07-27 |
Update Frequency |
Irregular |
Temporal Coverage |
N/A |
Spatial Coverage |
United States |
Source | John Snow Labs; National Center for Immunization and Respiratory Diseases; |
Source License URL | |
Source License Requirements |
N/A |
Source Citation |
N/A |
Keywords | US Vaccine, FDA Vaccine, Vaccine NDC |
Other Titles | US Vaccines National Drug Codes Unit Of Use, Vaccines NDC Codes Unit Of Use |
Data Fields
Name | Description | Type | Constraints |
---|---|---|---|
NDC_Inner_ID | ID of inner NDC | integer | level : Nominalrequired : 1 |
Use_Unit_Labeler | The Labeler code for the unit of use | string | required : 1 |
Use_Unit_Product | The product code for the unit of use | string | required : 1 |
Use_Unit_Package | The package code for the unit of use | string | required : 1 |
Use_Unit_Prop_Name | Proprietary name for the unit of sale | string | required : 1 |
Use_Unit_Generic_Name | The generic name for the unit of sale vaccine | string | - |
Use_Unit_Labeler_Name | The labeler name for the unit of use | string | required : 1 |
Use_Unit_Start_Date | The begin sale date for the unit of use | date | - |
Use_Unit_End_Date | The end sale date for the unit of use | date | - |
Use_Unit_Pack_Form | The packaging form of the unit of use | string | - |
CVX_Code | CVX for unit of sale NOTE that for some vaccines that have separate vaccine components, the CVX will map to the combined vaccine. | integer | level : Nominal |
CVX_Short_Description | Short description of CVX | string | - |
Is_No_Inner | True unit of use and unit of sale have same NDC | boolean | required : 1 |
NDC | NDC normalized to 11 characters with dashes between components. | string | - |
Last_Updated_Date | The date this record was last updated | date | - |
GTIN | GTIN (barcode) for Unit of use | string | - |
Data Preview
NDC Inner ID | Use Unit Labeler | Use Unit Product | Use Unit Package | Use Unit Prop Name | Use Unit Generic Name | Use Unit Labeler Name | Use Unit Start Date | Use Unit End Date | Use Unit Pack Form | CVX Code | CVX Short Description | Is No Inner | NDC | Last Updated Date | GTIN |
722 | 43528 | 2 | 1 | HEPLISAV-B | HEPATITIS B VACCINE (RECOMBINANT) | Dynavax Technologies Corporation | 2018-01-01 | 2020-01-01 | vial | 189 | HepB-CpG | False | 43528-0002-01 | 2020-01-21 | 343528002010.0 |
3009 | 50090 | 3469 | 9 | HEPLISAV-B | HEPATITIS B VACCINE (RECOMBINANT) | A-S Medication Solutions | 2018-01-01 | 2020-01-01 | Vial | 189 | HepB-CpG | False | 50090-3469-09 | 2020-01-21 | |
3013 | 43528 | 3 | 1 | HEPLISAV-B | HEPATITIS B VACCINE (RECOMBINANT) | Dynavax Technologies Corporation | 2018-01-01 | SYRINGE | 189 | HepB-CpG | False | 43528-0003-01 | 2023-02-02 | 343528003017.0 | |
376 | 58160 | 806 | 1 | HIBERIX | HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | GlaxoSmithKline Biologicals SA | 2009-08-24 | 2011-12-15 | VIAL | 48 | Hib (PRP-T) | False | 58160-0806-01 | 2018-06-08 | 358160806018.0 |
694 | 58160 | 816 | 5 | Hiberix | HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | GlaxoSmithKline Biologicals SA | 2015-12-21 | VIAL | 48 | Hib (PRP-T) | False | 58160-0816-05 | 2019-05-06 | 10358160816052.0 | |
697 | 58160 | 816 | 1 | Hiberix | HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE) | GlaxoSmithKline Biologicals SA | 2015-12-21 | VIAL | 48 | Hib (PRP-T) | False | 58160-0816-01 | 2023-02-01 | 10358160816014.0 | |
360 | 49281 | 248 | 58 | IMOVAX RABIES | RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | Sanofi Pasteur Inc. | 2013-09-30 | 2021-12-07 | VIAL, SINGLE-USE | 175 | Rabies - IM Diploid cell culture | False | 49281-0248-58 | 2022-05-16 | 349281248580.0 |
3049 | 49281 | 246 | 58 | IMOVAX RABIES | RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | Sanofi Pasteur Inc. | 2019-10-25 | VIAL, 1 mL, SINGLE-USE | 175 | Rabies - IM Diploid cell culture | False | 49281-0246-58 | 2023-02-02 | 349281246586.0 | |
378 | 58160 | 810 | 1 | INFANRIX | DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED | GlaxoSmithKline Biologicals SA | 2009-07-24 | 2022-12-14 | VIAL | 20 | DTaP | False | 58160-0810-01 | 2022-12-16 | 10358160810012.0 |
3028 | 50090 | 2883 | 9 | INFANRIX | DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED | A-S Medication Solutions | 2018-09-21 | 2023-01-06 | SYRINGE | 20 | DTaP | False | 50090-2883-09 | 2023-01-13 |